Randomized Trialhigh evidence
Molecular background behind lateral elbow pain reduction with Leukocyte-Rich and Leukocyte-Poor Platelet-Rich Plasma-randomized control trial and single-cell platelet analysis.
International orthopaedics·February 1, 2026·PMID 41579194
Why it mattersFor clinicians using PRP for tennis elbow, this study suggests that PRP formulation matters: leukocyte-poor preparations may perform better than leukocyte-rich products and placebo, which is directly relevant to injection selection and protocol design.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled